More than 1,000 industry leaders to share best practices and discuss the hottest topics on precision medicine and the digital transformation of life sciences
NEW YORK - November 11, 2019 - Medidata NEXT NYC, the premier conference on the digital transformation of life sciences, is set for November 12-13 at Spring Studios in New York City. Medidata NEXT NYC, the centerpiece of Medidata’s global conference series, will feature keynote addresses by healthcare industry visionaries, including:
Breakout sessions will highlight best practice advances within each phase of the clinical development lifecycle, including study planning and execution, trial management, data analytics, patient engagement, risk-based monitoring, and launch readiness. Medidata customers and partners, including senior executives and experts from global study sponsors and clinical research organizations (CROs), will lead more than 80 percent of these sessions.
Medidata NEXT NYC will also host a one-day hackathon, Real Patients, Virtual Trials, to inspire innovation around patient-centric clinical trials. The hackathon will help spur innovators to create novel mobile applications, using the Medidata AppConnect software kit, to increase virtual participation and patient recruitment rates in clinical trials.
“Every aspect of developing new life sciences products is changing thanks to rapid advances in the digital world,” said Glen de Vries, co-CEO and co-founder, Medidata. “Medidata NEXT NYC is part of our commitment to bring life science companies together for the common mission of improving people’s lives by connecting the dots from research, development, and the real-world practice of medicine.”
Medidata NEXT is the largest annual event series of its kind, and attracts over 3,000 leaders in drug and device development, clinical operations, data management, biostatistics, and digital medicine innovation industries. These professionals gather for networking and learning across six Medidata NEXT conferences in Basel, London, New York, Seoul, Shanghai and Tokyo.
Medidata is leading the digital transformation of life sciences, creating hope for millions of patients. Medidata helps generate evidence and insights to help pharmaceutical, biotech, medical device, and diagnostics companies, and academic researchers accelerate value, minimize risk, and optimize outcomes. More than one million registered users across 1,400 customers and partners access the world's most-used platform for clinical development, commercial, and real-world data. Medidata, a Dassault Systèmes company (Euronext Paris: #13065, DSY.PA), is headquartered in New York City and has offices around the world to meet the needs of its customers. Discover more at www.medidata.com and follow us @Medidata, The Operating System for Life SciencesTM.
Medidata, Rave, and myMedidata are registered trademarks of Medidata Solutions, Inc., a wholly-owned subsidiary of Dassault Systèmes.
Dassault Systèmes, the 3DEXPERIENCE Company, is a catalyst for human progress. We provide business and people with collaborative virtual environments to imagine sustainable innovations. By creating 'virtual twin experiences’ of the real world with our 3DEXPERIENCE platform and applications, our customers push the boundaries of innovation, learning and production.
Dassault Systèmes’ 20,000 employees are bringing value to more than 290,000 customers of all sizes, in all industries, in more than 140 countries. For more information, visit https://www.3ds.com